These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33264213)

  • 1. Kawasaki Disease and Kawasaki Disease Shock Syndrome Hospitalization Rates in the United States, 2006-2018.
    Maddox RA; Person MK; Kennedy JL; Leung J; Abrams JY; Haberling DL; Schonberger LB; Belay ED
    Pediatr Infect Dis J; 2021 Apr; 40(4):284-288. PubMed ID: 33264213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease.
    Gamez-Gonzalez LB; Moribe-Quintero I; Cisneros-Castolo M; Varela-Ortiz J; Muñoz-Ramírez M; Garrido-García M; Yamazaki-Nakashimada M
    Pediatr Int; 2018 Sep; 60(9):781-790. PubMed ID: 29888440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children.
    Gámez-González LB; Murata C; Muñoz-Ramírez M; Yamazaki-Nakashimada M
    Eur J Pediatr; 2013 Mar; 172(3):337-42. PubMed ID: 23152158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
    Li Y; Zheng Q; Zou L; Wu J; Guo L; Teng L; Zheng R; Jung LKL; Lu M
    Pediatr Rheumatol Online J; 2019 Jan; 17(1):1. PubMed ID: 30611297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007.
    Holman RC; Belay ED; Christensen KY; Folkema AM; Steiner CA; Schonberger LB
    Pediatr Infect Dis J; 2010 Jun; 29(6):483-8. PubMed ID: 20104198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations of Kawasaki disease shock syndrome: a case-control study.
    Chen PS; Chi H; Huang FY; Peng CC; Chen MR; Chiu NC
    J Microbiol Immunol Infect; 2015 Feb; 48(1):43-50. PubMed ID: 23927822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki Disease Hospitalizations in the United States 2016-2020: A Comparison of Before and During the Coronavirus Disease 2019 Era.
    Phamduy TT; Smith S; Herbst KW; Phamduy PT; Brimacombe M; Hogan AH; Salazar JC; Sturm J
    Pediatr Infect Dis J; 2021 Nov; 40(11):e407-e412. PubMed ID: 34382611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rising hospitalization rates of Kawasaki Disease in Chile between 2001 and 2007.
    Borzutzky A; Hoyos-Bachiloglu R; Cerda J; Talesnik E
    Rheumatol Int; 2012 Aug; 32(8):2491-5. PubMed ID: 21785955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kawasaki disease shock syndrome complicated with macrophage activation syndrome in a 5-month old boy: A case report.
    Lin Y; Shi L; Deng YJ; Liu Y; Zhang HW
    Medicine (Baltimore); 2019 Jan; 98(4):e14203. PubMed ID: 30681594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and Resource Utilization in Kawasaki Disease Hospitalizations in the United States, 2008-2017.
    Vasudeva R; Poku FA; Thommana M; Parmar G; Umscheid J; Parmar N; Koranteng CA; Singh A; Patel K; Yagnik P; Donda K; Bhatt P; Dapaah-Siakwan F
    Hosp Pediatr; 2022 Mar; 12(3):257-266. PubMed ID: 35106586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyponatremia Is a Feature of Kawasaki Disease Shock Syndrome: A Case-Control Study.
    Schuster JE; Palac HL; Innocentini N; Rowley AH; Young LT; Shulman ST
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):386-388. PubMed ID: 28177492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA.
    Okubo Y; Nochioka K; Sakakibara H; Testa M; Sundel RP
    Clin Rheumatol; 2017 Feb; 36(2):413-419. PubMed ID: 27987089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shock and unresponsiveness to repeated courses of intravenous immunoglobulin in Kawasaki disease: a nationwide database study.
    Liang YC; Chang CH; Lin MT; Kao FY; Huang SK; Wu MH
    Pediatr Res; 2020 Apr; 87(5):961-966. PubMed ID: 31711068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Clinical Features and Inflammatory Markers between Kawasaki Disease Shock Syndrome and Kawasaki Disease without Shock: A Meta-Analysis.
    Zhang H; Zheng Q; Li F
    J Healthc Eng; 2021; 2021():1486089. PubMed ID: 34966519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000.
    Holman RC; Curns AT; Belay ED; Steiner CA; Schonberger LB
    Pediatrics; 2003 Sep; 112(3 Pt 1):495-501. PubMed ID: 12949272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Kawasaki disease shock syndrome in children.
    Zhao Z; Yuan Y; Gao L; Li Q; Wang Y; Zhao S
    Front Immunol; 2024; 15():1400046. PubMed ID: 38887295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based study of Kawasaki disease shock syndrome in Taiwan.
    Lin MT; Fu CM; Huang SK; Huang SC; Wu MH
    Pediatr Infect Dis J; 2013 Dec; 32(12):1384-6. PubMed ID: 23748909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kawasaki disease: A brief history.
    Burns JC; Kushner HI; Bastian JF; Shike H; Shimizu C; Matsubara T; Turner CL
    Pediatrics; 2000 Aug; 106(2):E27. PubMed ID: 10920183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study.
    Park WY; Lee SY; Kim GB; Song MK; Kwon HW; Bae EJ; Choi EH; Park JD
    BMC Pediatr; 2021 Jan; 21(1):25. PubMed ID: 33413220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and an early predictive model for Kawasaki disease shock syndrome in Chinese children.
    Zhang M; Wang C; Li Q; Wang H; Li X
    Ital J Pediatr; 2024 Feb; 50(1):22. PubMed ID: 38310292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.